Medicare Equipment Moratorium: Addressing Fraud and Ensuring Access

The Centers for Medicare & Medicaid Services (CMS) has implemented a six-month moratorium on new suppliers of durable medical equipment (DME), prosthetics, orthotics, and supplies (DMEPOS) nationwide, effective January 1, 2024. This action aims to combat widespread fraud, waste, and abuse within this critical sector of healthcare, while ensuring continued access to essential medical equipment for beneficiaries.

The Scope of the Problem: Fraud in the DMEPOS Industry

The DMEPOS industry has long been plagued by fraudulent activities, leading to significant financial losses for Medicare. Fraudulent schemes often involve billing for equipment that was never provided, billing for unnecessary items, or submitting claims for services that weren’t medically necessary. According to CMS data, improper payments in this sector have reached substantial levels. Between 2015 and 2017, Medicare improperly paid approximately $34 million to DMEPOS suppliers, and an additional $22.7 million between 2018 and 2024 CMS Press Release.

Administrator of the Centers for Medicare & Medicaid Services, Chiquita Brooks-LaSure, emphasized the severity of the issue, stating that the agency is taking decisive action to protect taxpayer dollars and ensure the integrity of the Medicare program CMS Press Release.

What Does the Moratorium Entail?

The moratorium temporarily halts the enrollment of new DMEPOS suppliers in specific states and territories. It does not affect existing, compliant suppliers, and will not disrupt the delivery of necessary equipment to current Medicare beneficiaries. The pause specifically impacts suppliers of items such as:

• Wheelchairs
• Artificial limbs
• Oxygen tanks and supplies
• Gauze and wound care supplies
• Urinary catheters
• Breast prostheses

CMS has previously utilized similar moratoriums to address fraud in other healthcare sectors, including home health agencies and ambulance suppliers. Federal law allows for extensions of the six-month pause if necessary Federal Register Notice.

Why is This Happening Now?

The decision to implement the moratorium followed a comprehensive analysis of Medicare enrollment and claims data. This analysis revealed a concerning pattern of fraudulent activity and identified a demand for stricter oversight of the DMEPOS industry. The goal is to create a more level playing field for legitimate suppliers and to protect Medicare beneficiaries from substandard care and potentially harmful equipment.

Additional Measures to Combat Fraud

Alongside the moratorium, CMS is implementing several other initiatives to strengthen fraud prevention efforts:

• Fraud Tipline: A dedicated tipline will be established to allow individuals to report suspected fraud within the DMEPOS industry.
• Increased Scrutiny of Existing Suppliers: CMS will intensify its audits and investigations of current DMEPOS suppliers to identify and address any instances of non-compliance.
• Funding Halt to Minnesota Medicaid: CMS has temporarily halted $259.5 million in funding to Minnesota Medicaid due to concerns about improper payments and program integrity Star Tribune.

Key Takeaways

• A six-month moratorium is in effect for new DMEPOS suppliers nationwide.
• The moratorium aims to curb widespread fraud, waste, and abuse in the DMEPOS industry.
• Existing suppliers will not be affected, and beneficiaries will continue to receive necessary equipment.
• CMS is implementing additional measures, including a fraud tipline and increased scrutiny of existing suppliers.

Looking Ahead

The success of this moratorium will depend on CMS’s ability to effectively enforce the new regulations and to address the underlying issues that contribute to fraud within the DMEPOS industry. Continued vigilance and proactive measures will be crucial to protecting Medicare beneficiaries and ensuring the long-term sustainability of the program.